U.S. Cancer Death Rates Fall, but Liver Cancer Death Rate Rises

Translate to Spanish or other 102 languages!

Dr. Jeffrey Drebin
Dr. Jeffrey Drebin

Mega Doctor News

- Advertisement -

U.S. death rates from liver cancer have risen steadily since 2000, resulting in the disease going from the ninth-leading cause of cancer death to the sixth, a new report finds.

According to a report published by the Centers for Disease Control and Prevention, the change comes as U.S. cancer death rates overall — meaning rates for all combined cancers — have declined since 1990.

But from 2000 to 2016, liver cancer death rates in adults ages 25 and up rose 43 percent, from 7.2 deaths per 100,000 people in 2000 to 10.3 deaths per 100,000 people in 2016, the report found. The rates increased for both men and women; however, the death rates for men were 2 to 2.5 times higher than the rates for women throughout the study period.

- Advertisement -

Death rates for other cancers — such as lung, colon and breast cancers — have fallen thanks to lower rates of people getting these cancers, as well as better ways to detect and treat these cancers, said Dr. Jeffrey Drebin, chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center in New York City and a liver cancer surgeon. Drebin was not involved with the new report.

Liver cancer, however, hasn’t seen similar improvements, Drebin told Live Science. For example, the rates of people getting liver cancer haven’t changed much, and the disease is still difficult to detect and, in many cases, treat.

Drebin noted that although the rates of liver cancer due to some causes — such as hepatitis B, a viral infection that causes inflammation of the liver — have decreased, the rates of the disease due to other causes — including obesity-related cirrhosis, or scarring of the liver — have gone up. Therefore, the rates of people getting liver cancer due to different causes are “probably balanced out,” he said.

What’s more, even though new drugs are available to treat hepatitis C, another viral infection that causes liver inflammation, these drugs “may not prevent the eventual development of liver cancer,” Drebin said.

- Advertisement -

Liver cancer death rates were the highest in adults ages 75 and up during the entire study period, the report found. Death rates rose for adults in this age group during the study period, as well as for adults ages 65 to 74 and adults ages 55 to 64. Adults ages 45 to 54 saw an increase in death rates from 2000 to 2005, followed by a decrease in rates from 2012 to 2016. Liver cancer death rates for adults ages 25 to 44 did not change during the study period.

Drebin noted that liver cancer rates rise with age because of the long-term effects of liver inflammation. (In other words, the longer a person has inflammation of the liver, the more likely that person is to develop liver cancer.)

Looking at death rates by race and ethnicity, the report found that death rates rose in Hispanic, non-Hispanic black and non-Hispanic white adults from 2000 to 2016. Liver cancer death rates fell for one group during the study period: non-Hispanic Asian or Pacific Islander. This group, however, had the highest liver cancer death rate of all the groups in 2000.

The report also found that, after adjusting for age, liver cancer death rates in 2016 were the highest in Washington, D.C. (16.8 deaths per 100,000 people) and the lowest in Vermont (6 deaths per 100,000 people).

The report is based on data from the National Vital Statistics System, a database that contains death certificates from all 50 states and the District of Columbia.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Enhances Ear, Nose, and Throat Care with Addition of Dr. Tess Hill

As part of its ongoing commitment to expanding access to outstanding healthcare throughout the Rio Grande Valley, DHR Health is pleased to welcome Dr. Tess Hill to its growing team of physicians. Dr. Hill joins DHR Health as an otolaryngologist (ear, nose and throat physician) and looks forward to providing compassionate, patient-centered care.

McAllen Cancer Survivor Takes Her Fight for Patients to Washington

For breast cancer survivor Elvia Gibbs, traveling from McAllen to Washington, D.C., was about more than advocating for legislation. It was an opportunity to tell lawmakers firsthand that cancer research and access to clinical trials can mean more time, hope, and quality of life for patients.

DHR Health’s Free Seminar on Breakthrough Treatment for Stroke Survivors, Sept. 19th

DHR Health’s Neuroscience Institute will host a free seminar for stroke survivors who want improved hand and arm movement as many stroke survivors experience impaired mobility and loss of function in the arm which can significantly affect their ability to   perform everyday activities.

DHR Health Transplant Success Signals a New Era for Advanced Medicine in the Rio Grande Valley

The significance of DHR Health Transplant Institute’s latest recognition extends far beyond a hospital ranking. It raises a larger question for South Texas: Has the Rio Grande Valley reached the point where patients can look to the region not only for local healthcare, but for nationally competitive transplant medicine?
- Advertisement -